Regular ArticleCorticotropin-Releasing Hormone Protects Neurons against Insults Relevant to the Pathogenesis of Alzheimer's Disease
References (65)
- et al.
The in vivo proconvulsant effects of corticotropin releasing hormone in the developing rat are independent of ionotropic glutamate receptor activation
Dev. Brain Res.
(1998) - et al.
Inhibition of receptor-mediated calcium responses by corticotrophin-releasing hormone in the CATH.a cell line
Neuropharmacology
(1999) - et al.
Influence of corticotrophin releasing factor on neuronal death in vitro and in vivo
Brain Res.
(2000) - et al.
Cell loss in supraoptic and paraventricular nucleus in Alzheimer's disease
Brain Res.
(1993) Corticotropin-releasing factor receptors: Physiology, pharmacology, biochemistry and role in central nervous system and immune disorders
Psychoneuroendocrinology
(1995)- et al.
A biphasic regulation of receptor mRNA expressions for growth hormone, glucocorticoid and mineralocorticoid in the rat dentate gyrus during acute stress
Brain Res.
(2000) - et al.
Intraneuronal Aβ42 accumulation in human brain
Am. J. Pathol.
(2000) - et al.
Hypothalamic-pituitary-adrenal system function in patients with Alzheimer's disease
Neurobiol. Aging
(1995) Transgenic mice expressing Alzheimer amyloid precursor proteins
Exp. Gerontol.
(1998)- et al.
Dietary restriction selectively decreases glucocorticoid receptor expression in the hippocampus and cerebral cortex of rats
Exp. Neurol.
(2000)
Corticotropin releasing factor antagonist reduces ischemic hippocampal neuronal injury
Brain Res.
(1991)
Astressin, a novel and potent CRF antagonist, is neuroprotective in the hippocampus when administered after a seizure
Brain Res.
(1997)
Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist
Eur. J. Pharmacol.
(1997)
The role of the hippocampal mineralocorticoid and glucocorticoid receptors in the hypothalamo-pituitary-adrenal axis of the aged Fisher rat
Mol. Cell. Neurosci.
(1994)
Differential distribution of urocortin- and corticotropin-releasing factor-like immunoreactivities in the rat brain
Neuroscience
(1999)
Blunted adrenocorticotropin and increased adrenal steroid response to human corticotropin-releasing hormone in Alzheimer's disease
Biol. Psychiatry
(1996)
The lipid peroxidation product 4-hydroxynonenal impairs glutamate and glucose transport and choline acetyltransferase activity in NSC-19 motor neuron cells
Exp. Neurol.
(1999)
Increased corticotropin-releasing factor immunoreactivity in select brain sites following kainate-elicited seizures
Brain Res.
(1998)
CSF corticotropin-releasing factor (CRF) in Alzheimer's disease: Its relationship to severity of dementia and monoamine metabolites
Biol. Psychiatry
(1989)
Age-related changes in the dog hypothalamic-pituitary-adrenocortical system: Neuroendocrine activity and corticosteroid receptors
J. Steroid Biochem. Mol. Biol.
(1991)
Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development
Neuron
(1998)
Corticotrophin-releasing factor antagonist inhibits neuronal damage induced by focal cerebral ischemia or activation of NMDA receptors in the rat brain
Brain Res.
(1994)
Brain corticosteroid receptor gene expression and neuroendocrine dynamics during aging
J. Steroid Biochem. Mol. Biol.
(1991)
Cortisol secretion and Alzheimer's disease progression
Biol. Psychiatry
(1997)
The role of corticotropin-releasing factor in depression and anxiety disorders
J. Endocrinol.
(1999)
Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease
Nature
(1995)
Corticotropin-releasing factor (CRF), CRF-binding protein (CRF-BP), and CRF/CRF-BP complex in Alzheimer's disease and control postmortem human brain
J. Neurochem.
(1997)
Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice
Nat. Neurosci.
(1999)
Synthesis and oral efficacy of a 4-(butylethylamino)pyrrolo[2,3-d]pyrimidine: A centrally active corticotropin-releasing factor1 receptor antagonist
J. Med. Chem.
(1997)
A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease
Nature
(2000)
Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation
Nat. Med.
(1999)
Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2
Nat. Genet.
(2000)
Cited by (0)
Copyright © 2001 Academic Press. All rights reserved.